Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways
Jing Li(Wuhan University), Qizhu Tang(Wuhan University), Chunru Xu(Wuhan University), Ning Zhang(Tianjin Children's Hospital), Chun‐Xia Wan(Wuhan University), Si‐Chi Xu(Wuhan University), Jie Ren(Xiamen University), Yu‐Pei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofeng Zeng(East China Jiaotong University)
Cited by 37
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study
|Annals of the Rheumatic Diseases|2010|460
FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
|Cell Death and Differentiation|2019|452
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396